Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): A Phase 3 Randomized Multicenter Trial to Compare Hepatic Progression-Free Survival Following Bland Embolization, Lipiodol Chemoembolization, and Drug-Eluting Bead C

Project: Research project

StatusFinished
Effective start/end date11/11/1511/9/19

Funding

  • University of Pennsylvania (Subaward # 567893(10049930))
  • Guerbet LLC (Subaward # 567893(10049930))